Table 4.
Lesion classification.
| Variable | Matched SSC | ||||
|---|---|---|---|---|---|
| Dermatologist Diagnosis n = 528 (%) |
GP Diagnosis n = 548 (%) |
p-Value | Histological Diagnosis n = 113 (%) |
p-Value | |
| Benign | 343 (65) | 237 (43) | 32 (28) | ||
| Pre-malignant | 52 (10) | 19 (4) | 5 (4) | ||
| Malignant | 116 (22) | 181 (33) | 76 (67) | ||
| Uncertain | 17 (3) | 111 (20) | N/A | ||
| <0.001 | <0.001 | ||||
| Benign:malignant | 3.0 | 1.3 | 0.4 | ||
| 2020 VLC | |||||
| Dermatologist Diagnosis n = 277 * (%) |
GP diagnosis n = 172 (%) |
p-Value | Histology Diagnosis n = 33 (%) |
p-Value | |
| Benign | 177 (64) | 30 (17) | 11 (33) | ||
| Pre-malignant | 40 (14) | 11 (6) | 2 (6) | ||
| Malignant | 52 (19) | 18 (11) | 20 (61) | ||
| Uncertain | 8 (3) | 113 (38) | N/A | ||
| <0.001 | 0.09 | ||||
| Benign:malignant | 3.4 | 1.7 | 0.6 | ||
| 2016 VLC | |||||
| Dermatologist Diagnosis n = 680 * (%) |
GP Diagnosis n = 603 (%) |
p-Value | Histology Diagnosis n = 122 (%) |
p-Value | |
| Benign | 460 (67) | 149 (25) | 21 (17) | ||
| Pre-malignant | 65 (10) | 16 (3) | 14 (11) | ||
| Malignant | 121 (18) | 183 (30) | 87 (71) | ||
| Uncertain | 34 (5) | 255 (42) | N/A | ||
| <0.001 | <0.001 | ||||
| Benign:malignant | 3.8 | 0.8 | 0.2 | ||
SSC—suspected skin cancer pathway; VLC—virtual lesion clinic; GP—general practitioner; N/A—not applicable; IEC—intraepithelial carcinoma; SCC—squamous cell carcinoma; BCC—basal cell carcinoma. * Includes extra lesions identified by nurse specialist during VLC.